Glucocorticoids (GC) may expose patients to the risk of diabetes, particularly with long term use.

This approval is an example of artificial intelligence being used to improve the health of our patients with diabetes and will get us closer to a true artificial pancreas.

Does intensive glucose control show heart benefits in long-term followup?. 

The persistence of benefits of dapagliflozin over saxagliptin might change therapy choices in patients with type 2 diabetes.

How to identify who is at risk for the progression of diabetic kidney disease to end-stage renal disease?

When hospitals do not employ best practices in glucose control, patients with diabetes experience worse outcomes at greater costs.

New research attempts to untangle the conflicting literature on whether statins and SSTIs are linked.

Results from a retrospective cohort comparing metformin vs. sulfonylurea use in reduced kidney function.

What are the long-term effects of teplizumab on C-peptide response?

DE-MRI shows asymptomatic patients are undergoing small, silent heart attacks.